Merck KGaA (OTCMKTS:MKKGY) Releases Quarterly Earnings Results, Misses Expectations By $0.19 EPS

Key Points

• Merck KGaA (OTCMKTS:MKKGY) reported Q EPS of $0.28, missing the consensus of $0.47 by $0.19, and posted revenue of $6.11 billion versus expected $6.20 billion.
• Shares dropped to $25.76 on elevated volume after the release; the company trades at a PE of 10.26 with a market cap around $16.65 billion.
• Deutsche Bank downgraded Merck KGaA from Buy to Hold, and the stock’s average analyst rating on MarketBeat is currently Hold.

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.28 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.19), Zacks reports. Merck KGaA had a net margin of 13.92% and a return on equity of 10.07%. The firm had revenue of $6.11 billion for the quarter, compared to analysts' expectations of $6.20 billion.

Merck KGaA Stock Performance

Shares of OTCMKTS MKKGY traded down $0.73 during mid-day trading on Friday, hitting $25.76. The stock had a trading volume of 174,695 shares, compared to its average volume of 75,617. The firm has a market cap of $16.65 billion, a PE ratio of 10.26, a PEG ratio of 5.82 and a beta of 0.96. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.97 and a current ratio of 1.49. The company has a 50 day moving average of $29.64 and a two-hundred day moving average of $27.62. Merck KGaA has a twelve month low of $24.32 and a twelve month high of $31.00.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft downgraded Merck KGaA from a "buy" rating to a "hold" rating in a research report on Tuesday, February 3rd. Three research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of "Hold".

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck's Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.